NCT04954703 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

De Maeseneer M, Boulet C, Willekens I, Lenchik L, De Mey J, Cattrysse E, Shahabpour M
Segond fracture: involvement of the iliotibial band, anterolateral ligament, and anterior arm of the biceps femoris in knee trauma. Skeletal Radiol. 2015 Mar;44(3):413-21. doi: 10.1007/s00256-014-2044-x. Epub 2014 Dec 4.
Fredericson M, Wolf C
Iliotibial band syndrome in runners: innovations in treatment. Sports Med. 2005;35(5):451-9. Review.
Holzer M, Padberg F
Intermittent theta burst stimulation (iTBS) ameliorates therapy-resistant depression: a case series. Brain Stimul. 2010 Jul;3(3):181-3. doi: 10.1016/j.brs.2009.10.004. Epub 2009 Nov 1.
Khaund R, Flynn SH
Iliotibial band syndrome: a common source of knee pain. Am Fam Physician. 2005 Apr 15;71(8):1545-50. Review.
Subotnick SI
Limb length discrepancies of the lower extremity (the short leg syndrome). J Orthop Sports Phys Ther. 1981;3(1):11-6.

Effects of Myofascial Release of IT Band With or Without Muscle Energy Technique of Gluteus Maximus and Tensor Fascia Lata With Iliotibial Band Syndrome.

Details for clinical trial NCT04954703

Clinical trial NCT04954703 - References